Skip to content

INMB - Inmune Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

INmune Bio Inc

INMB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

INMBINmune Bio Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.44
52-wk low: $1.09
Prev close: $1.82
Mkt cap: $61.9M
Beta: 0.90
P/S: 760.3x

Smart money

Checking federal contract awards

Coverage gaps for INMB

No tracked fund holdings this quarter
No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings

Reported Aug 6, 2026

Earnings came in 75.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $62M

Valuation

P/S760.34
P/B2.88

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: INMB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $61.89M
Beta: 0.90

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.9x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-74.8%

10-K

Earnings per share

-$0.05+75.0%

-$0.20 expected

Next report

What the street expects next

-74.8%

ROA-39.1%

Growth

Beta0.90